Full-Time
Veeva Systems
5,001-10,000 employees
Quality and regulatory software solutions provider
No salary listed
Expert
Company Historically Provides H1B Sponsorship
London, UK
The company has offices in more than 15 countries around the world.
- 10+ years of experience in web development
- Experience with both frontend (React) and backend development, including API design (REST, GraphQL)
- Familiarity with real-time communication protocols (WebSockets, gRPC) and complex state management solutions
- Strong understanding of design principles and accessibility guidelines (WCAG)
- Excellent problem-solving skills and a proactive approach to addressing challenges
- A keen eye for detail, meticulousness, and a commitment to delivering exceptional results
- The ability to effectively communicate, collaborate, and influence others
- Fluency in written and spoken English
- Design and implement innovative and scalable frontend architectures for complex web applications
- Lead the development team in defining and implementing coding standards, best practices, and development processes
- Collaborate closely with designers and back-end developers to ensure seamless integration and a consistent user experience
- Develop and maintain reusable UI components and design systems to ensure code consistency and maintainability
- Implement real-time collaboration features and manage complex state management in web applications
- Stay up-to-date with the latest frontend technologies and frameworks, and evaluate their suitability for project needs
- Mentor and guide front-end developers, fostering a culture of continuous learning and improvement
- Conduct code reviews, providing constructive feedback to ensure code quality and adherence to standards
- Clearly communicate technical ideas and decisions to both technical and non-technical stakeholders
- Identify and proactively address potential issues and risks, offering solutions and alternatives
- Experience in a lead/architect role
- Knowledge of design systems methodologies (e.g., Atomic Design)
- Experience with cloud platforms (e.g., AWS, Azure, GCP)
- Experience with continuous integration and continuous delivery (CI/CD) pipelines
- Completed university degree in relevant field
Veeva Systems offers software solutions for quality, regulatory, and advertising claims management, focusing on consumer products and chemical companies. Their cloud-based platform provides visibility and traceability throughout the product journey, ensuring compliance with regulations while improving efficiency. Veeva stands out by addressing the specific challenges of the chemical and consumer goods markets, building on its experience in the life sciences sector. The company's goal is to help clients bring safe and compliant products to market faster through a subscription-based model.
Company Size
5,001-10,000
Company Stage
IPO
Headquarters
Pleasanton, California
Founded
2007
Simplify's Take
What believers are saying
- Increased AI-driven analytics adoption enhances data accuracy and reduces time-to-market.
- Decentralized clinical trials demand cloud solutions, aligning with Veeva's infrastructure.
- Growing regulatory scrutiny boosts demand for Veeva's compliance management software.
What critics are saying
- Emerging cloud-based software providers threaten Veeva's market share.
- Rapid technological advancements may increase Veeva's R&D costs.
- Economic downturns could reduce client spending and affect revenue growth.
What makes Veeva Systems unique
- Veeva Systems specializes in cloud-based software for the life sciences industry.
- The company offers end-to-end visibility and traceability in product journeys.
- Veeva's subscription model ensures continuous updates and improvements for clients.
Help us improve and share your feedback! Did you find this helpful?
Benefits
Parental leave
PTO
Free food
Health, dental, & vision insurance
Gym membership reimbursement
Growth & Insights and Company News
6 month growth
↑ 0%1 year growth
↑ 1%2 year growth
↑ 0%Specialized CRO standardizes on Veeva RTSM to drive operational efficiency and faster study timelinesBARCELONA, Spain, March 19, 2025 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced that Indero, formerly Innovaderm Research, successfully launched its 40th RTSM study on Veeva RTSM. By standardizing with Veeva RTSM, Indero has strengthened its clinical trial operations, harnessing advanced RTSM capabilities and expert support to drive efficiency, enhance process consistency, and streamline execution."As we continue to optimize our clinical trial operations, Veeva RTSM has driven more efficient processes and closer collaboration to ensure seamless execution," said Eric Hardy, senior director, biometrics at Indero. "Because of this added speed and effectiveness, we can help bring therapies to market faster, allowing our sponsors, sites, and patients to benefit sooner."The launch of Indero's 40th RTSM study highlights the continued collaboration between the two organizations. Since first adopting Veeva RTSM, Indero has worked closely with Veeva to continuously refine and implement standardized processes that drive long-term success for its clinical trials."With its enterprise standard RTSM approach, Indero is achieving greater long-term efficiency and reliability in their studies," said Steve Simmerman, general manager, Veeva RTSM. "Partnering with Indero to standardize clinical processes will further accelerate study timelines, demonstrating a streamlined approach that can advance the industry."Additional InformationTo learn more about Veeva's enterprise standard RTSM, visit www.veeva.com/rtsm.About Veeva SystemsVeeva is the global leader in cloud software for the life sciences industry. Committed to innovation, product excellence, and customer success, Veeva serves more than 1,000 customers, ranging from the world's largest biopharmaceutical companies to emerging biotechs
Since first adopting Veeva RTSM, Indero has worked closely with Veeva to continuously refine and implement standardized processes that drive long-term success for its clinical trials.
Veeva Systems (NYSE:VEEV) announces Tina Hunt's retirement from board before 2025 shareholders meeting.
Ms. Hunt, who has served as a director on Veeva's board, will not stand for re-election at the upcoming 2025 Annual Meeting.
Top 20 biopharma goes live with Veeva Development Cloud to speed the delivery of treatments for currently incurable diseasesINGELHEIM, Germany and BARCELONA, Spain, March 11, 2025 /PRNewswire/ -- Today, Boehringer Ingelheim and Veeva Systems (NYSE: VEEV) have announced the launch of Boehringer's One Medicine Platform, powered by the successful implementation of Veeva Development Cloud. They first announced the One Medicine collaboration in March 2022. The unified platform brings together data and processes across clinical, regulatory, and quality, enabling Boehringer to streamline its product development. With the One Medicine Platform, Boehringer can seamlessly connect data across functions, optimize trial efficiency and collaboration with research sites, and accelerate the delivery of new medicines to treat currently incurable diseases."Together with Veeva, Boehringer has advanced its approach to clinical trials and is fulfilling our pledge to accelerate the delivery of innovative, life-transforming treatments to patients across the world," said Oliver Fink, head of learning, process and digitalization at Boehringer Ingelheim. "Veeva Development Cloud provides the technology foundation for Boehringer's One Medicine Platform, giving our teams the flexibility to design and run studies with greater speed, efficiency, and compliance.""By connecting clinical, regulatory, and quality on Veeva Development Cloud, Boehringer unifies data and breaks down silos across teams to accelerate drug development and approvals," said Rik van Mol, senior vice president, Veeva Development Cloud. "This is an exciting milestone toward realizing Veeva and Boehringer's shared mission to advance the use of data and technology to modernize clinical trials and deliver better patient outcomes."Veeva Development Cloud is the technology foundation for product development, bringing together clinical, quality, regulatory, and safety applications to simplify end-to-end business processes and deliver process excellence.Additional InformationFor more on Veeva Development Cloud, visit: veeva.com/DevelopmentCloudAbout Boehringer IngelheimBoehringer Ingelheim is a biopharmaceutical company active in both human and animal health